HIF1A and breast carcinoma: Baseline and second core needle biopsy (pre-zoledronic acid treatment) and surgery (post-zoledronic acid treatment) immunohistochemistry (IHC) scores of HIF-1α staining and clinical outcomes of primary endocrine therapy in primary breast carcinoma patients